Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Schipper

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Advances in Radiation Oncology|June 13, 2022
Investigating the Incidence of Pulmonary Abnormalities as Identified by Parametric Response Mapping in Patients With Lung Cancer Before Radiation TreatmentDaniel R Owen, Yilun Sun, Jim C Irrer, et al.
Cancer Causes & Control : CCC|May 29, 2024
Time-varying associations of patient and tumor characteristics with cancer survival: an analysis of SEER data across 14 cancer sites, 2004-2017Emily K Roberts, Lingfeng Luo, Alison M Mondul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2017
Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of lifePeter G Hawkins, Jae Y Lee, Yanping Mao, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2020
Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metricsJoel R Wilkie, Michelle L Mierzwa, Keith A Casper, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 20, 2018
Dosimetric impact of interfractional organs at risk variation during high-dose rate interstitial brachytherapy for gynecologic malignanciesPeter G Hawkins, Ming Tang, Karen A Vineberg, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2025
Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality CollaborativeSteven G Allen, Caitlin A Schonewolf, Matthew J Schipper, et al.
Translational Oncology|May 12, 2019
Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver InjuryKyle C Cuneo, Theresa Devasia, Yilun Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparingAvraham Eisbruch, Lon H Marsh, Laura A Dawson, et al.
JAMA Oncology|August 11, 2017
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical TrialMary Feng, Krithika Suresh, Matthew J Schipper, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Advances in Radiation Oncology|June 13, 2022
Investigating the Incidence of Pulmonary Abnormalities as Identified by Parametric Response Mapping in Patients With Lung Cancer Before Radiation TreatmentDaniel R Owen, Yilun Sun, Jim C Irrer, et al.
Cancer Causes & Control : CCC|May 29, 2024
Time-varying associations of patient and tumor characteristics with cancer survival: an analysis of SEER data across 14 cancer sites, 2004-2017Emily K Roberts, Lingfeng Luo, Alison M Mondul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2017
Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of lifePeter G Hawkins, Jae Y Lee, Yanping Mao, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2020
Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metricsJoel R Wilkie, Michelle L Mierzwa, Keith A Casper, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 20, 2018
Dosimetric impact of interfractional organs at risk variation during high-dose rate interstitial brachytherapy for gynecologic malignanciesPeter G Hawkins, Ming Tang, Karen A Vineberg, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2025
Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality CollaborativeSteven G Allen, Caitlin A Schonewolf, Matthew J Schipper, et al.
Translational Oncology|May 12, 2019
Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver InjuryKyle C Cuneo, Theresa Devasia, Yilun Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparingAvraham Eisbruch, Lon H Marsh, Laura A Dawson, et al.
JAMA Oncology|August 11, 2017
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical TrialMary Feng, Krithika Suresh, Matthew J Schipper, et al.
Pageof 13